Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email


Check back regularly for news, coverage, and announcements about MAVA.


NeuWave Medical, Inc. Announces $14 Million Financing Led by H.I.G. BioVentures to Further Commercial Success of Microwave-Based Ablation Tools

Medical device company, NeuWave Medical, announced today that it has raised a $14 million Series B financing, led by new investor H.I.G. BioVentures, with participation from existing shareholders, including Venture Investors, WARF and the State of Wisconsin Investment Board. The financing will be utilized to further the commercial success of the company’s market-leading Certus 140 thermal ablation system and to continue the company’s pioneering development of novel interventional and surgical tools. Concurrent with the financing, H.I.G. BioVentures Managing Director, Michael Wasserman, will join the NeuWave Board of Directors.

Read More